ALL SESSIONS

Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immuno-therapies

Antibody Drug Conjugates

Antibody-Drug Conjugates

Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immuno-therapies

Antibody Drug Conjugates

Antibody-Drug Conjugates

Industry Sponsored

View Sessions

UPCOMING

Join us for
our roundtable in
||
latest advances in
||
your questions on
||
new therapies for
||
practice changes in
||
your patient cases in

LUNG CANCER — The Year In Review

Charles Rudin

USA

Solange Peters

Switzerland

Martin Reck

Germany

Agenda & Discussion Topics

DRUGGABLE SINCE 2025: New Approvals and Emerging Options

Solange Peters

The Year of SCLC: From hope to practice

Charles Rudin

Highlights in Targeted Therapies and ADCs

Martin Reck

2 CME Points

EACCME® & SGMO

Join our host, Solange Peters, for our Virtual Lung Summit on the newest advances in lung cancer care. This interdisciplinary session brings together leading experts to synthesize the most important findings of the past year and translate them into practical, real-world strategies. We’ll explore newly approved therapies, key updates in targeted treatments, and the evolving role of immunotherapy across NSCLC and SCLC. Don’t miss this opportunity to deepen your understanding, take part in the discussion, and come away with clear takeaways on the developments reshaping lung cancer treatment.
Register here

Do You Already Have An Account?
No need to sign up again: as a verified user, you will have access to all our sessions. Simply login to participate in this event.


First Time On Lung Summit?

SIGN UP NOW

This session is kindly supported by our partners with no influence on the content

Amgen
AstraZeneca
BeOne
Roche
PharmaMar
MSD

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates